Dose-Response Relationship of a Web-Based Tailored Intervention Promoting Human Papillomavirus Vaccination: Process Evaluation of a Randomized Controlled Trial.

HPV vaccination dose-response relationship informed decision making intervention use process evaluation randomized controlled trial web-based tailored intervention

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
17 07 2020
Historique:
received: 26 05 2019
accepted: 14 05 2020
revised: 04 11 2019
pubmed: 11 6 2020
medline: 12 1 2021
entrez: 11 6 2020
Statut: epublish

Résumé

In the Netherlands, human papillomavirus (HPV) vaccination uptake remains low. To improve informed decision making (IDM) and HPV vaccination acceptability, we systematically developed an interactive, web-based tailored intervention to which mothers of Dutch girls were invited to participate. The aim of this study was to provide insight into the intervention's working mechanisms by evaluating (1) program use, (2) program acceptability, and (3) the relationship of program use with program acceptability and intervention effects (ie, dose-response relationship). Only mothers from the intervention arm of a randomized controlled trial that assessed the effectiveness of the web-based, tailored intervention were included in this study. They were invited to visit the website of the web-based intervention between baseline (January 2015, just before access to the intervention) and follow up (March 2015, prior to the first HPV vaccination). Indicators for program use were time of website use (ie, duration of intervention exposure) and completeness (ie, proportion of all available web pages visited). HPV vaccination uptake registered by Praeventis was used as the primary outcome. Secondary outcomes were IDM, decisional conflict, and social-psychological determinants of HPV vaccination uptake. Among the 3995 invited mothers, 2509 (62.80%) logged on to the website, 2239 of whom (89.24%) visited at least one page of the intervention components. On average, mothers spent 21.39 minutes (SD 12.41) on the website and completed 50.04% (SD 26.18%) of the website components. Participants rated the website 7.64 (SD 1.39) on a 10-point scale. Program acceptability was significantly associated with completeness (β=4.36, P<.001), but not with time of website use (β=-.07, P=.77). Intention-to-treat analysis (N=3995) showed a significant positive effect of completeness on all outcome measures (all P<.003; Bonferroni-corrected α=.05/15 factors), including on HPV vaccination uptake. Time of website use had a significant positive effect on all outcomes (all P<.003), except for uptake (P=.20), risk perception when not vaccinated (P=.14), subjective norms (P=.03), and habit (P=.01). Program use and acceptability of the intervention were adequate. Completeness was positively associated with acceptability. Furthermore, positive effects (ie, dose-response effects) were found for completeness and time of website use on the mothers' IDM, decisional conflict, and almost all of the social-psychological determinants of HPV vaccination acceptability. In addition, the extent to which mothers completed the intervention had a positive impact on their daughters' vaccination uptake. This indicates that the web-based, tailored intervention fits well with the mothers' needs, and that completeness of use is essential for improving HPV vaccination uptake, acceptability, and IDM. Program use should therefore be promoted. Netherlands Trial Register NTR4795; https://www.trialregister.nl/trial/4795.

Sections du résumé

BACKGROUND
In the Netherlands, human papillomavirus (HPV) vaccination uptake remains low. To improve informed decision making (IDM) and HPV vaccination acceptability, we systematically developed an interactive, web-based tailored intervention to which mothers of Dutch girls were invited to participate.
OBJECTIVE
The aim of this study was to provide insight into the intervention's working mechanisms by evaluating (1) program use, (2) program acceptability, and (3) the relationship of program use with program acceptability and intervention effects (ie, dose-response relationship).
METHODS
Only mothers from the intervention arm of a randomized controlled trial that assessed the effectiveness of the web-based, tailored intervention were included in this study. They were invited to visit the website of the web-based intervention between baseline (January 2015, just before access to the intervention) and follow up (March 2015, prior to the first HPV vaccination). Indicators for program use were time of website use (ie, duration of intervention exposure) and completeness (ie, proportion of all available web pages visited). HPV vaccination uptake registered by Praeventis was used as the primary outcome. Secondary outcomes were IDM, decisional conflict, and social-psychological determinants of HPV vaccination uptake.
RESULTS
Among the 3995 invited mothers, 2509 (62.80%) logged on to the website, 2239 of whom (89.24%) visited at least one page of the intervention components. On average, mothers spent 21.39 minutes (SD 12.41) on the website and completed 50.04% (SD 26.18%) of the website components. Participants rated the website 7.64 (SD 1.39) on a 10-point scale. Program acceptability was significantly associated with completeness (β=4.36, P<.001), but not with time of website use (β=-.07, P=.77). Intention-to-treat analysis (N=3995) showed a significant positive effect of completeness on all outcome measures (all P<.003; Bonferroni-corrected α=.05/15 factors), including on HPV vaccination uptake. Time of website use had a significant positive effect on all outcomes (all P<.003), except for uptake (P=.20), risk perception when not vaccinated (P=.14), subjective norms (P=.03), and habit (P=.01).
CONCLUSIONS
Program use and acceptability of the intervention were adequate. Completeness was positively associated with acceptability. Furthermore, positive effects (ie, dose-response effects) were found for completeness and time of website use on the mothers' IDM, decisional conflict, and almost all of the social-psychological determinants of HPV vaccination acceptability. In addition, the extent to which mothers completed the intervention had a positive impact on their daughters' vaccination uptake. This indicates that the web-based, tailored intervention fits well with the mothers' needs, and that completeness of use is essential for improving HPV vaccination uptake, acceptability, and IDM. Program use should therefore be promoted.
TRIAL REGISTRATION
Netherlands Trial Register NTR4795; https://www.trialregister.nl/trial/4795.

Identifiants

pubmed: 32520718
pii: v22i7e14822
doi: 10.2196/14822
pmc: PMC7395256
doi:

Banques de données

NTR
['NTR4795']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14822

Informations de copyright

©Mirjam Pot, Theo G W M Paulussen, Robert A C Ruiter, Liesbeth Mollema, Miranda Hofstra, Hilde M Van Keulen. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 17.07.2020.

Références

Cancer. 2008 Nov 15;113(10 Suppl):3036-46
pubmed: 18980286
J Clin Pathol. 2002 Apr;55(4):244-65
pubmed: 11919208
Health Promot Pract. 2005 Apr;6(2):134-47
pubmed: 15855283
J Occup Rehabil. 2011 Sep;21(3):410-20
pubmed: 21258848
J Clin Oncol. 2011 Nov 10;29(32):4294-301
pubmed: 21969503
BMC Public Health. 2008 Jun 19;8:216
pubmed: 18565222
J Adolesc Health. 2009 Nov;45(5):528-31
pubmed: 19837361
Prev Sci. 2012 Apr;13(2):173-82
pubmed: 21993613
Front Psychol. 2012 Apr 17;3:111
pubmed: 22529829
BMC Public Health. 2012 Jan 25;12:80
pubmed: 22276600
J Med Internet Res. 2010 Feb 17;12(1):e4
pubmed: 20164043
J Med Internet Res. 2015 Jul 10;17(7):e172
pubmed: 26163456
Prev Med. 2017 Jul;100:41-49
pubmed: 28389328
Emotion. 2006 Nov;6(4):670-4
pubmed: 17144758
J Med Internet Res. 2010 Sep 02;12(3):e37
pubmed: 20813716
J Med Internet Res. 2014 Feb 13;16(2):e48
pubmed: 24550153
PLoS One. 2013;8(2):e57067
pubmed: 23437310
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
J Health Psychol. 2009 Jan;14(1):78-87
pubmed: 19129340
Sex Transm Dis. 2013 May;40(5):401-5
pubmed: 23588130
JMIR Res Protoc. 2013 Jan 16;2(1):e3
pubmed: 23612363
Health Psychol. 2010 Jan;29(1):29-39
pubmed: 20063933
JMIR Hum Factors. 2017 Jan 27;4(1):e4
pubmed: 28130203
Psychooncology. 2012 Jul;21(7):695-705
pubmed: 21538678
J Med Internet Res. 2015 Oct 07;17(10):e228
pubmed: 26446779
J Womens Health (Larchmt). 2015 Nov;24(11):950-7
pubmed: 26488269
Health Promot Int. 2015 Sep;30(3):803-15
pubmed: 24101160
Health Educ Res. 2008 Jun;23(3):427-39
pubmed: 18209115
BMC Res Notes. 2012 Oct 03;5:548
pubmed: 23034161
Implement Sci. 2007 Nov 30;2:40
pubmed: 18053122
Health Educ Res. 2016 Aug;31(4):555-62
pubmed: 27343254
J Med Internet Res. 2013 Jan 28;15(1):e14
pubmed: 23353649
J Med Internet Res. 2012 Nov 14;14(6):e152
pubmed: 23151820
J Med Internet Res. 2011 Jan 06;13(1):e2
pubmed: 21212045
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Arch Pathol Lab Med. 2003 Aug;127(8):930-4
pubmed: 12873163
Health Educ Res. 2009 Aug;24(4):699-720
pubmed: 19286893
Interact J Med Res. 2016 May 25;5(2):e16
pubmed: 27226146
Health Psychol. 2014 Sep;33(9):986-97
pubmed: 24274808
Euro Surveill. 2012 Apr 26;17(17):
pubmed: 22551495
J Clin Epidemiol. 2006 Sep;59(9):920-5
pubmed: 16895814
Patient Educ Couns. 2002 Sep;48(1):87-91
pubmed: 12220754
J Epidemiol Community Health. 2014 Feb;68(2):101-2
pubmed: 24022816
Eur J Cancer Care (Engl). 2015 Sep;24(5):673-82
pubmed: 25132146
J Med Internet Res. 2013 Aug 19;15(8):e170
pubmed: 23958584
J Med Internet Res. 2017 Sep 06;19(9):e312
pubmed: 28877862
Front Public Health. 2018 Sep 28;6:226
pubmed: 30356852
BMC Public Health. 2013 Feb 06;13:111
pubmed: 23388344
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Health Expect. 2001 Jun;4(2):99-108
pubmed: 11359540
Psychol Health. 2014;29(11):1227-44
pubmed: 24798208
Psychol Bull. 2007 Jul;133(4):673-93
pubmed: 17592961
J Med Internet Res. 2016 Sep 26;18(9):e225
pubmed: 27670222
Implement Sci. 2007 Nov 26;2:38
pubmed: 18039362
J Med Internet Res. 2011 Apr 14;13(2):e32
pubmed: 21493191
J Obstet Gynecol Neonatal Nurs. 2002 Sep-Oct;31(5):570-81
pubmed: 12353737
J Med Internet Res. 2013 Jul 16;15(7):e146
pubmed: 23859884
BMJ Open. 2016 Jan 27;6(1):e009875
pubmed: 26817639
Soc Sci Med. 2009 Aug;69(3):475-80
pubmed: 19540642
J Am Coll Health. 2014;62(1):32-8
pubmed: 24313694
J Med Internet Res. 2008 Nov 21;10(5):e45
pubmed: 19033146
J Med Internet Res. 2012 Aug 20;14(4):e109
pubmed: 22903145

Auteurs

Mirjam Pot (M)

Child Health, Netherlands Organization for Applied Scientific Research (TNO), Leiden, Netherlands.

Theo Gwm Paulussen (TG)

Child Health, Netherlands Organization for Applied Scientific Research (TNO), Leiden, Netherlands.

Robert Ac Ruiter (RA)

Department of Work and Social Psychology, Maastricht University, Maastricht, Netherlands.

Liesbeth Mollema (L)

National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, Netherlands.

Miranda Hofstra (M)

Child Health, Netherlands Organization for Applied Scientific Research (TNO), Leiden, Netherlands.

Hilde M Van Keulen (HM)

Child Health, Netherlands Organization for Applied Scientific Research (TNO), Leiden, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH